<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/285a–6" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/285a–6/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/285a–6/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_285a_6"><akn:num>285a–6</akn:num><akn:heading>Breast and gynecological cancers</akn:heading><akn:content><akn:p>§ 285a–6. Breast and gynecological cancers(a) Expansion and coordination of activitiesThe Director of the Institute, in consultation with the National Cancer Advisory Board, shall expand, intensify, and coordinate the activities of the Institute with respect to research on breast cancer, ovarian cancer, and other cancers of the reproductive system of women.


(b) Coordination with other institutesThe Director of the Institute shall coordinate the activities of the Director under subsection (a) with similar activities conducted by other national research institutes and agencies of the National Institutes of Health to the extent that such Institutes 11 So in original. Probably should not be capitalized. and agencies have responsibilities that are related to breast cancer and other cancers of the reproductive system of women.


(c) Programs for breast cancer(1) In generalIn carrying out subsection (a), the Director of the Institute shall conduct or support research to expand the understanding of the cause of, and to find a cure for, breast cancer. Activities under such subsection shall provide for an expansion and intensification of the conduct and support of—(A) basic research concerning the etiology and causes of breast cancer;

(B) clinical research and related activities concerning the causes, prevention, detection and treatment of breast cancer;

(C) control programs with respect to breast cancer in accordance with section 285a–1 of this title, including community-based programs designed to assist women who are members of medically underserved populations, low-income populations, or minority groups;

(D) information and education programs with respect to breast cancer in accordance with section 285a–2 of this title; and

(E) research and demonstration centers with respect to breast cancer in accordance with section 285a–3 of this title, including the development and operation of centers for breast cancer research to bring together basic and clinical, biomedical an</akn:p></akn:content><akn:subsection eId="subsec_285a_6_a"><akn:num>(a)</akn:num><akn:heading>Expansion and coordination of activities</akn:heading><akn:content><akn:p>(a) Expansion and coordination of activities The Director of the Institute, in consultation with the National Cancer Advisory Board, shall expand, intensify, and coordinate the activities of the Institute with respect to research on breast cancer, ovarian cancer, and other cancers of the reproductive system of women.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285a_6_b"><akn:num>(b)</akn:num><akn:heading>Coordination with other institutes</akn:heading><akn:content><akn:p>(b) Coordination with other institutes The Director of the Institute shall coordinate the activities of the Director under subsection (a) with similar activities conducted by other national research institutes and agencies of the National Institutes of Health to the extent that such Institutes 11 So in original. Probably should not be capitalized. and agencies have responsibilities that are related to breast cancer and other cancers of the reproductive system of women.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285a_6_c"><akn:num>(c)</akn:num><akn:heading>Programs for breast cancer</akn:heading><akn:content><akn:p>(c) Programs for breast cancer</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285a_6_d"><akn:num>(d)</akn:num><akn:heading>Other cancers</akn:heading><akn:content><akn:p>(d) Other cancers In carrying out subsection (a), the Director of the Institute shall conduct or support research on ovarian cancer and other cancers of the reproductive system of women. Activities under such subsection shall provide for the conduct and support of—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285a_6_e"><akn:num>(e)</akn:num><akn:heading>Report</akn:heading><akn:content><akn:p>(e) Report The Director of the Institute shall prepare, for inclusion in the biennial report submitted under section 284b 33 See References in Text note below. of this title, a report that describes the activities of the National Cancer Institute under the research programs referred to in subsection (a), that shall include—</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>